ConductScience.org, home

Gene · 5037

Papers2,820

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Transient Expression of Bta78 Gene in Nicotiana benthamiana Enhances Whitefly Feeding Activity.Arch Insect Biochem Physiol202642574659PubTator, text miningPubMed
The FT/TFL1 Regulatory Module: A Synthesis of Gene Duplication, Functional Divergence, and Environmental Modulation Across Plant Lineages.Plant Cell Environ202642449555PubTator, text miningPubMed
Construction of a ferroptosis-related prognostic signature and identification of SRSF9 as a key biomarker in lung adenocarcinoma.Transl Cancer Res202642445428PubTator, text miningPubMed
The cross-talk between GSK-3β, RKIP, and PTEN as potential targets for therapeutic implications in cancer: a comprehensive insight.J Pharm Pharm Sci202642428556PubTator, text miningPubMed
Palmatine restores airway epithelial barrier function of asthma by inhibiting Alox15-mediated ferroptosis.Phytomedicine202642391816PubTator, text miningPubMed
Molecular characterization and correlation with β-lactam resistance of penicillin-binding protein2x, 2b, and 1a of Streptococcus pneumoniae in clinical pneumococcal isolates.Microbiol Spectr202642390257PubTator, text miningPubMed
Beyond Raf-1 inhibition: RKIP's multifaceted roles in cellular homeostasis.Biochim Biophys Acta Rev Cancer202642323054PubTator, text miningPubMed
Synthetic heterocyclic scaffolds relevant to human 15-lipoxygenase-2 (h15-LOX-2) inhibition: Scaffold diversity, structure-activity relationships, selectivity challenges, and future directions.Eur J Med Chem202642284635PubTator, text miningPubMed
Nacubactam: a review on mechanistic insights and therapeutic promise for combating β-lactam resistance among multidrug-resistant Gram-negative pathogens.Ann Med Surg (Lond)202642254231PubTator, text miningPubMed
Prognostic and therapeutic significance of RKIP and YY1 in cancer, autoimmune disorders, and inflammatory pathologies.Biochim Biophys Acta Rev Cancer202642214770PubTator, text miningPubMed
Alternative splicing of FLOWERING LOCUS T1 fine-tunes bud dormancy release in hybrid poplar.Plant Physiol202642200263PubTator, text miningPubMed
Potential circadian rhythm-related pathogenic genes in diabetic nephropathy: a multi-omics Mendelian randomization study.Ren Fail202642178167PubTator, text miningPubMed
PEBP1 inhibition as a therapeutic target for neurological recovery in ischemic stroke.Neurotherapeutics202642066623PubTator, text miningPubMed
Research Progress on Sex Pheromone Receptors in Insects.Insects202642042424PubTator, text miningPubMed
P. falciparum PEBP protein is dispensable during asexual and sexual stages of development.Front Cell Infect Microbiol202641994201PubTator, text miningPubMed
Germplasm screening and genome-wide PEBP profiling identify key regulators of photoperiod-insensitive flowering in winged bean (Psophocarpus tetragonolobus L).BMC Genomics202641992089PubTator, text miningPubMed
Rational design framework for fluorescent biosensors from periplasmic binding proteins.Biosci Rep202641983621PubTator, text miningPubMed
Expression Analysis of Selected microRNAs in Diabetes Mellitus Visceral Fat Tissues.J Obes202641960718PubTator, text miningPubMed
Circular RNAs in cancer: Its biogenesis, functions, relationships with cancer progression, applications in immunotherapy and biomarker potentials.Cancer Immunol Immunother202641915211PubTator, text miningPubMed
Emerging Molecular Insights and Therapeutic Directions in Neurofibromatosis Type 1 and NF2-Related Schwannomatosis.Int J Mol Sci202641898726PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/5037/papers